A Coordinated Attack: Rett Syndrome Therapeutic Development.


Journal

Trends in pharmacological sciences
ISSN: 1873-3735
Titre abrégé: Trends Pharmacol Sci
Pays: England
ID NLM: 7906158

Informations de publication

Date de publication:
04 2019
Historique:
received: 16 11 2018
revised: 06 02 2019
accepted: 06 02 2019
entrez: 26 3 2019
pubmed: 25 3 2019
medline: 17 4 2019
Statut: ppublish

Résumé

Rett syndrome (RTT) is a neurodevelopmental disorder caused by mutations in the Methyl CpG binding protein 2 (MeCP2) gene. This Science & Society article focuses on pharmacological strategies that attack RTT treatment from multiple angles, including drug repurposing and de novo discovery efforts, and discusses the impacts of preclinical study design and translationally relevant outcome measures.

Identifiants

pubmed: 30905360
pii: S0165-6147(19)30038-0
doi: 10.1016/j.tips.2019.02.007
pmc: PMC6482467
mid: NIHMS1024467
pii:
doi:

Substances chimiques

MECP2 protein, human 0
Methyl-CpG-Binding Protein 2 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-236

Subventions

Organisme : NIMH NIH HHS
ID : K01 MH112983
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH113543
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

Nat Genet. 1999 Oct;23(2):185-8
pubmed: 10508514
J Biol Chem. 2002 Jun 14;277(24):21453-7
pubmed: 11967257
J Neurosci. 2006 Jan 4;26(1):319-27
pubmed: 16399702
Neuron. 2006 Feb 2;49(3):341-8
pubmed: 16446138
Science. 2007 Feb 23;315(5815):1143-7
pubmed: 17289941
Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):14230-5
pubmed: 22891354
Dis Model Mech. 2012 Nov;5(6):733-45
pubmed: 23115203
Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9941-6
pubmed: 24958891
Pediatr Neurol. 2015 Nov;53(5):402-11
pubmed: 26278631
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):751-6
pubmed: 26733678
Trends Neurosci. 2016 Feb;39(2):100-113
pubmed: 26830113
Hum Mol Genet. 2016 May 15;25(10):1990-2004
pubmed: 26936821
Biol Psychiatry. 2016 May 1;79(9):710-2
pubmed: 27079494
J Neurodev Disord. 2017 Jun 12;9:7
pubmed: 28616096
Sci Transl Med. 2017 Aug 16;9(403):
pubmed: 28814546
Pediatr Neurol. 2017 Nov;76:37-46
pubmed: 28964591
Ann Clin Transl Neurol. 2017 Dec 27;5(2):118-127
pubmed: 29468173
J Pharmacol Exp Ther. 2018 May;365(2):291-300
pubmed: 29523700
Wien Med Wochenschr. 1966 Sep 10;116(37):723-6
pubmed: 5300597
Ann Neurol. 1983 Oct;14(4):471-9
pubmed: 6638958

Auteurs

Rocco G Gogliotti (RG)

Vanderbilt Department of Pharmacology and Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA.

Colleen M Niswender (CM)

Vanderbilt Department of Pharmacology and Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA; Vanderbilt Kennedy Center, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: Colleen.niswender@vanderbilt.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH